| HOME >> BIOLOGY >> TECHNOLOGY |
New FDA-approved medical device "is specifically designed to objectively measure cardiopulmonary gas exchange in heart failure patients. It can make a dramatic difference in treating CRT patients." Dr. Abraham Kocheril, Professor of Medicine and Director of Clinical Electrophysiology at the University of Illinois at Chicago
Minneapolis-St. Paul, MN (PRWEB) May 6, 2009 -- The University of Illinois Medical Center, the primary teaching facility for the UIC College of Medicine (the nation's largest medical school), is the first such institution to install and begin using the innovative Shape-HF™ Cardiopulmonary Testing System. Developed by Shape Medical Systems, Inc., this non-invasive medical device assesses heart-lung interaction and ventilation in patients with chronic heart failure and other cardiopulmonary disease. While gas exchange testing devices have been used for several years to measure cardiopulmonary response to exercise, Shape-HF™ is the first device specifically designed for cardiology. Shape-HF™ is FDA-approved, easy to use, easy on the patient, and provides clinically relevant data that is easy to understand, reproducible and immediately useful to a cardiologist.
Upon being introduced to the Shape-HF™ System, Dr. Abraham Kocheril, Professor of Medicine and Director of Clinical Electrophysiology at the University of Illinois at Chicago, saw immediate applications for the device. "It broadens the pool of heart failure patients we are able to accurately test because it is less cumbersome than existing cardiopulmonary testing devices and
'/>"/>
| Source: PRWeb Copyright©2009 Vocus, Inc. All rights reserved |